Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Oncolys BioPharma, Inc. ( (JP:4588) ) has provided an update.
Oncolys BioPharma Inc. reported a decrease in net sales for the nine months ending September 30, 2025, with significant operating and ordinary losses compared to the previous year. The company’s financial position weakened, with a notable decline in total assets and net assets, reflecting ongoing challenges in its operations and market environment.
The most recent analyst rating on (JP:4588) stock is a Hold with a Yen726.00 price target. To see the full list of analyst forecasts on Oncolys BioPharma, Inc. stock, see the JP:4588 Stock Forecast page.
More about Oncolys BioPharma, Inc.
Oncolys BioPharma Inc. is a company listed on the Tokyo Stock Exchange, operating in the biopharmaceutical industry. The company focuses on developing innovative treatments for cancer and serious infectious diseases.
Average Trading Volume: 938,353
Technical Sentiment Signal: Buy
Current Market Cap: Yen20.73B
For a thorough assessment of 4588 stock, go to TipRanks’ Stock Analysis page.